KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Debt Ratio: 2009-2024

Historic Debt Ratio for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to 0.45.

  • Teva Pharmaceutical Industries' Debt Ratio fell 7.32% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.72, marking a year-over-year decrease of 6.98%. This contributed to the annual value of 0.45 for FY2024, which is 0.87% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Debt Ratio stood at 0.45 for FY2024, which was down 0.87% from 0.46 recorded in FY2023.
  • Teva Pharmaceutical Industries' Debt Ratio's 5-year high stood at 0.51 during FY2020, with a 5-year trough of 0.45 in FY2024.
  • In the last 3 years, Teva Pharmaceutical Industries' Debt Ratio had a median value of 0.46 in 2023 and averaged 0.46.
  • In the last 5 years, Teva Pharmaceutical Industries' Debt Ratio climbed by 9.32% in 2020 and then dropped by 5.55% in 2021.
  • Over the past 5 years, Teva Pharmaceutical Industries' Debt Ratio (Yearly) stood at 0.51 in 2020, then decreased by 5.55% to 0.48 in 2021, then decreased by 0.30% to 0.48 in 2022, then declined by 5.36% to 0.46 in 2023, then fell by 0.87% to 0.45 in 2024.